Management of peripheral lymph node tuberculosis in routine practice: an unselected 10-year cohort

Area of Science:

• Medicine
• Infectious Diseases
• Pulmonology

Background:

• Tuberculosis (TB) lymph node behavior during chemotherapy can lead to clinical uncertainty and prolonged treatment.
• Varied responses necessitate a clearer understanding of treatment efficacy in real-world settings.

Purpose of the Study:

• To evaluate if routine practice outcomes for lymph node TB in Blackburn align with the British Thoracic Society's 6-month chemotherapy trial.
• To assess the effectiveness of standard TB chemotherapy in a high-incidence area.

Main Methods:

• Prospective recording of all TB cases at Blackburn Chest Clinic over a 10-year period.
• Identification and analysis of patients diagnosed with lymph node TB.
• Review of diagnostic procedures including fine-needle aspiration and lymph node biopsy, alongside culture confirmation.

Main Results:

• 100 patients with lymph node TB were identified.
• Diagnostic procedures like fine-needle aspiration and lymph node biopsy were utilized in a significant number of cases, with culture confirmation in 60.
• Observed sinus and new lymph node development mirrored the British Thoracic Society trial findings. Post-treatment, 10 patients showed new/enlarged nodes, but only three were confirmed relapses.

Conclusions:

• Six-month chemotherapy is effective for drug-susceptible lymph node TB in routine English practice.
• Clinical uncertainty arises from the variable behavior of lymph nodes during and after TB treatment.
• Careful investigation of new signs is essential to distinguish relapsed TB from typical post-treatment lymph node changes.